Antineoplaston Therapy in Treating Patients With Cancer of Unknown Primary Origin

Summary

Current therapies for Cancer of Unknown Primary Origin provide very limited benefit to the patient. The anti-cancer properties of Antineoplaston therapy suggest that it may prove beneficial in the treatment of Cancer of Unknown Primary Origin. PURPOSE: This study is being performed to determine the effects (good and bad) that Antineoplaston therapy has on patients with Cancer of Unknown Primary Origin.

Timeline

Start

1996-03-18

Primary completion

2005-02-02

Completion

2005-02-02

Drugs

Indications